Bankwell Financial Group Inc
F:33W
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bankwell Financial Group Inc
F:33W
|
US |
|
Ensurge Micropower ASA
F:B7X
|
NO |
|
P
|
Press Kogyo Co Ltd
F:2YO
|
JP |
|
E
|
Eisai Co Ltd
F:EII
|
JP |
|
P
|
Perpetual Energy Inc
F:AGG
|
CA |
|
Halcyon Agri Corporation Ltd
F:HAT
|
SG |
|
K
|
Kazia Therapeutics Ltd
F:NV9
|
AU |
|
Addex Therapeutics Ltd
F:APE
|
CH |
|
Septeni Holdings Co Ltd
OTC:SPIDY
|
JP |
|
E
|
Entourage Health Corp
F:4WE0
|
CA |
Wall St Price Targets
33W Price Targets Summary
Bankwell Financial Group Inc
According to Wall Street analysts, the average 1-year price target for 33W is 34.43 EUR with a low forecast of 28.27 EUR and a high forecast of 41.49 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 33W's stock price target?
Price Target
34.43
EUR
According to Wall Street analysts, the average 1-year price target for 33W is 34.43 EUR with a low forecast of 28.27 EUR and a high forecast of 41.49 EUR.
What is the Revenue forecast for Bankwell Financial Group Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 2 years is 13%.
What is the Net Income forecast for Bankwell Financial Group Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Net Income has been 31%. The projected CAGR for the next 2 years is 13%.
